Zobrazeno 1 - 2
of 2
pro vyhledávání: '"NS, nasal secretions"'
Autor:
Robert W. Kaminski, James Blanchard, Robert L. Wilson, Pamela A. Kozlowski, Anna Aldovini, Edwin V. Oaks, Morgan Singletary, Jeremy V. Camp
Publikováno v:
Vaccine: X, Vol 8, Iss, Pp 100105-(2021)
Vaccine: X
Vaccine: X
Development of intranasal vaccines for HIV-1 and other mucosal pathogens has been hampered by the lack of adjuvants that can be given safely to humans. We have found that an intranasal Shigella vaccine (Invaplex) which is well tolerated in humans can
Autor:
Camp JV; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA., Wilson RL; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA., Singletary M; Tulane National Primate Research Center, Division of Veterinary Medicine, Covington, LA 70433, USA., Blanchard JL; Tulane National Primate Research Center, Division of Veterinary Medicine, Covington, LA 70433, USA., Aldovini A; Departments of Medicine and Pediatrics, Children's Hospital and Harvard, Boston, MA 02115, USA., Kaminski RW; Department of Subunit Enteric Vaccines and Immunology, Division of Bacterial and Rickettsial Diseases, The Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA., Oaks EV; Department of Subunit Enteric Vaccines and Immunology, Division of Bacterial and Rickettsial Diseases, The Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA., Kozlowski PA; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Publikováno v:
Vaccine: X [Vaccine X] 2021 Jun 24; Vol. 8, pp. 100105. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).